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To analyze the value of facial nerve antidromic evoked potentials (FNAEPs) in predicting recovery from Bell palsy. Study Design.
Retrospective study using electrodiagnostic data and medical chart review. Methods. A series of 46 patients with unilateral Bell
palsy treated were included. According to taste test, 26 cases were associated with taste disorder (Group 1) and 20 cases were not
(Group 2). Facial function was established clinically by the Stennert system after monthly follow-up. The result was evaluated
with clinical recovery rate (CRR) and FNAEP. FNAEPs were recorded at the posterior wall of the external auditory meatus of both
sides. Results. Mean CRR of Group 1 and Group 2 was 61.63% and 75.50%. We discovered a statistical diﬀerence between two
groups and also in the amplitude diﬀerence (AD) of FNAEP. Mean ± SD of AD was −6.96% ± 12.66% in patients with excellent
result, −27.67% ± 27.70% with good result, and −66.05% ± 31.76% with poor result. Conclusions. FNAEP should be monitored
in patients with intratemporal facial palsy at the early stage. FNAEP at posterior wall of external auditory meatus was sensitive to
detect signs of taste disorder. There was close relativity between FNAEPs and facial nerve recovery.
1.Introduction
Bell palsy is a neuropathy of the peripheral seventh cranial
nerve, usually resulting from traumatic, compressive, infec-
tive, inﬂammatory, or metabolic abnormalities. However,
in many cases no etiology is identiﬁed, and the eventual
diagnosis is idiopathic [1]. Its annual incidence was from
0.011% to 0.040% [2]. For many patients, the questions that
whether their facial function will return to normal one day
and how long this is going to take are mostly concerned
about. Evaluation of the prognosis of Bell palsy is useful
for counseling of patients and guiding further management.
Since 1970s, prognostication has been based mainly on
various electrophysiologic tests [3–10], such as electromyo-
graphy (EMG), electroneurography (ENoG), maximal nerve
excitability testing, and facial motor nerve conduction
(MNC) testing. However, the electrophysiologic tests above
are facial nerve orthodromic evoked potentials. Abnormal
ﬁndings from these tests are obtained after the degeneration-
process extends to the extratemporal segment of the facial
nerve with 1- to 2-week delay [11]. Decompression surgery
cannot play a part in retrieve and prevent degeneration
after most of facial nerve function has already degenerated.
Therefore, if we want to detect nerve degeneration and to
predict facial function recovery during its early stages, it is
necessary to use a test that can diagnose degeneration within
1 week after the onset of paralysis.
The facial nerve antidromic evoked potentials (FNAEP)
was ﬁrst described by Bumm et al. in 1974 [12]. It is the
only one method to represent the intratemporal facial nerve
function [13]. It has the possibility to diagnose nerve degen-
erationduringtheearlystageofparalysis.Nakatanietal.[14]
had used FNAEP to value the prognosis of facial paralysis.
However, the correlativity of intra- or extra-temporal facial
nerve was not pointed out, and the quantitative analysis was
not obtained. The purpose of this study was to evaluate the
prognostic use of FNAEP quantitatively within three days in
a successive series of patients with Bell palsy associated with
or without taste disorder at a university-based center.2 International Journal of Otolaryngology
Table 1: Stennert system.
Facial paralysis symptoms Evaluating standard Secondary damage Evaluating standard
Static state Hyperacusis Yes
Bilateral palpebral ﬁssure diﬀerence ≥3mm Taste disorder Yes
Lower eyelid ectropion Yes Joint movement: Amount, eyes,
nasolabial fold, mouth and cheek Nasolabial fold loss Yes
Ptosis of labial angle ≥3mm Two among the above Yes
Movement Three among the above Yes
Frown No Blink (secondary spasm) Yes
Palpebral ﬁssure could not close: Contracture Yes
Sleeping Yes Tear secretion:
Maximum stimulation Yes Palpebral ﬁssure static ≥70% Yes
Grin: upper and lower canines Not visible <70% Yes
Upper lateral incisors Not visible 0% Yes
Whistle: distance between philtrum and mouth corner
on diseased side more than that on healthy side >50% Tear Yes
Acial paralysis index Secondary damage index
2. Patientsand Methods
2.1. Populations. From January to December 2010, there
were 46 patients with unilateral Bell palsy in a single center
(Department of Oral and Maxillofacial Surgery, Ninth
People’s Hospital, Shanghai Jiao Tong University School of
Medicine). Out of the patients, 23 were male and 23 were
f e m a l e .A g e sr a n g e df r o m1 9t o6 6y e a r s( m e a n ,4 3 . 5y r s ) .
The duration from onset to treatment was from 1 to 3 days
(mean, 2.9d). The right side was involved in 24 patients,
and the left was in 22 patients. The etiology was idiopathic.
The patients were divided into two groups: 26 patients
with taste disorder (Group 1) and 20 patients without
taste disorder (Group 2). Interventions given to the patients
were local physical therapy and pharmacotherapy, such as
high-dose prednisone within 3 days after onset, besides
methylcobalamin and vasodilators in 1 month after onset.
Forty-three patients (93.5%) were followed up with the
average follow-up period of 4.8 months (ranged from 1 to
9 months).
2.2. Clinical Evaluation of Facial Nerve Function. The initial
and ﬁnal facial nerve function was reported using the
Stennert system [15]( Table 1). Each indicator was scored
10. The score ranged from 0 to 200. Clinical recovery rate
(CRR) = (200 − follow-up score)/200 × 100%. The recovery
outcomes of facial nerve function was graded as follow:
excellent(CRR ≥80%),good(50% ≤CRR<80%),andpoor
(CRR <50%).
2.3. FNAEP Evaluation of the Facial Nerve Function. The
FNAEP device (Viking Quset, Nicolet Corp, USA) includes
bipolar stimulators, discoid electrodes, needle electrodes,
and monitor. The patients were examined by FNAEP for the
ﬁrst presentation at the clinic. Before the test, the cerumen
of external auditory canal was cleared and the degrease
cream was embrocated at the external auditory canal and
the earlobe. Ground wire was connected on a wrist. Two
discoid electrodes with a little conductive paste were located
at the posterior wall of the external auditory canal (recording
electrode) and the earlobe (reference electrode), respectively
(Figure 1). FNAEP was performed ﬁrst on the asymp-
tomatic side and then repeated on the symptomatic side.
The superﬁcial projection of the homolateral stylomastoid
foramen was stimulated by the bipolar stimulator with
band-pass ﬁltering of 2–10000Hz and stimulus intensity of
30mA. The results of both sides were recorded (Figure 2).
The amplitude diﬀerence (AD) and latency diﬀerence (LD)
between symptomatic side and asymptomatic side were
calculated according to the following formula:
AD =

amplitude of symptomatic side −amplitude of asymptomatic side

amplitude of asymptomatic side
×100%,
LD =

latency of symptomatic side −latency of asymptomatic side

latency of asymptomatic side
×100%.
(1)
2.4. Statistical Analysis. Statistical analysis of the data,
presented as means ± SD, was performed using SAS 8.1
software. The diﬀerence between “Group 1” and “Group 2”
was analyzed. Signiﬁcance was established when probabilityInternational Journal of Otolaryngology 3
Figure 1: The recording electrode of the posterior wall of the
external auditory canal (blue arrow) and the reference electrode of
posterior wall of the earlobe (black arrow).
was P<0.01. Statistical diﬀerence was established when
probability was 0.01 <P<0.05. No statistical diﬀerence was
established when probability was P>0.05.
3. Results
3.1. Clinical Facial Nerve Function. During the period of fol-
lowup, the mean CRR was 61.63% ± 18.90% (ranged from
30% to 90%) in Group 1. There were 6 cases (26.09%) with
excellent result, 12 cases (52.13%) with good result, and
5 cases (21.74%) with poor result. In Group 2, the mean
CRR was 75.50% (ranged from 50% to 100%). There were
12(60%) cases with excellent result, 8 cases (40%) with good
result, and no cases with poor result (Figure 3). There was a
statistical diﬀerence between the two groups (P = 0.0189 <
0.05).
3.2. FNAEP Results. T h em e a no fA Do fG r o u p1a n dG r o u p
2w e r e−33.88% and 5.47%. There was a signiﬁcant diﬀer-
encebetweenthem(P<0.01).Forthepatientswithexcellent
result, mean ± SD of AD and LD were −6.96% ± 12.66%
and 0.54% ± 7.23%. For the patients with good result,
mean ± SD of AD and LD were −27.67% ± 27.70% and
12.11% ± 7.23%. For the patients with poor result, mean ±
SD of AD and LD were −66.05% ± 31.76% and 23.36% ±
1.61% (Figure 4). There was a signiﬁcant diﬀerence of AD
between the “excellent” group and the “poor” group (P =
0.0014 < 0.01), and there were statistical diﬀerences between
the “excellent” group and the “good” group (P = 0.010 <
0.05) and between the “good” group and the “poor” group
(P = 0.0287 < 0.05). There was a statistical diﬀerence of
LD between the “excellent” group and the “poor” group
(P = 0.0124 < 0.05), and there was a signiﬁcant diﬀerence
between the “excellent” group and the “good” group (P =
0.0041 < 0.01) and no signiﬁcant diﬀerence between the
“good” group and the “poor” group (P = 0.2041 > 0.05).
4. Discussion
The majority of the drug treatments for Bell palsy at the
early stage are eﬀective. Nevertheless, those patients who are
not completely improved by medication deserved facial
nerve decompression surgery. Accordingly, for almost all the
patients, the questions that whether their facial function will
return to normal and the facial nerve decompression surgery
is necessary or not and when to take are mostly concerned
about. Evaluation of the prognosis of Bell palsy is useful
for counseling of patients and guiding further management.
Although electrical tests were already introduced to predict
theprognosisofBellpalsyinthe1970s,theywerestillcontro-
versial. As the facial nerve is stimulated out of the temporal
boneinthesetests,theevaluationofnervefunctionislimited
to the extratemporal facial nerve. There is general agreement
thatabnormalﬁndings fromthesetestsareobtainedafterthe
degeneration process extends to the extratemporal segment
of the facial nerve with 1-week delay [3–10]. We are not
able to obtain information about facial nerve damage in
the temporal bone at the early stage of facial palsy with
extratemporal electrodiagnostic tests, such as MNC, EMG,
and ENoG. Decompression surgery cannot play a part in
retrieve and prevent degeneration after most of the nerve
function has already degenerated. To raise therapeutic eﬀect,
we should precisely evaluate the poor outcome that patients
who suﬀered from Bell palsy are possible to gain before
completionoffacialnervedegeneration.Withregardstothis,
it is necessary to use a test that can diagnose degeneration
within 1 week after the onset of paralysis.
The FNAEP is the only method of monitoring a nerve
action potential, among all the electrodiagnostic tests of the
facial nerve [3–10]. Other than traditional electrophysiolog-
ical testing, FNAEP stimulated the extratemporal segment of
facial nerve and was recorded at the intratemporal segment.
If the lesion occurred, its amplitude would cause abnormal
changes, which provided strong evidence of intratemporal
location [16]. The waveform of this potential reaction was
more constant and had obvious time locked relationship
with the stimulus. Tashima et al. [17] reported that the re-
corder located at the posterior wall of external auditory
meatus could represent the vertical portion of facial nerve,
and the characteristic waveform of the FNAEP was also
revealed in animal experiments.
Taste disorder in facial paralysis implies the lesion of ver-
tical portion of facial nerve intratemporally. In this study, the
duration from onset to test was from 1 to 3 days, and the
mean of AD of Group 1 and Group 2 were −33.88% and
5.47%.Therewasasigniﬁcantdiﬀerencebetweenthem.Also,
there was a statistical diﬀerence of CRR between two groups.
Signiﬁcant abnormal of AD of FNAEP was correlative with
taste disorder. It was conﬁrmed that FNAEP can prompt
facialnervedamageinthetemporalbone,andrecorderatthe
posterior wall of external auditory meatus was appropriate.
Withthepreliminaryassessment,wefoundthattherelativity
between FNAEP amplitude and the clinical results was closer
than that between latency and the clinical results, and the
s y m p t o mo ft a s t ed i s o r d e rw o u l do c c u ri fA Do fF N A E Pw a s
lower than −30%. It was important to evaluate the nerve
function of intratemporal segment at the early stage. FNAEP
was the best choice to evaluate and predict the facial nerve
function at the early stage.
Herzon et al. [18] never applied FNAEP to evaluate
prognosis of facial paralysis. Comparison of FNAEP between4 International Journal of Otolaryngology
Figure 2: The waveform of FNAEP. A1–A4 show the recorders of asympotomatic side; A5–A8, which amplitude decreased (arrow), show
the recorders of sympotomatic side.
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Figure 3: The CRR in the group with taste disorder and the group
without taste disorder.
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Figure 4: Mean AD and LD in the groups with excellent, good, and
poor clinical results.
symptomatic side and asymptomatic side showed that the
clinical results were good when only amplitude was tem-
porarily discrete, and the results were poor while amplitude
obviously reduced. However, Herzon failed to obtain quanti-
tative analysis. According to our quantitative analysis, it was
preliminary considered that when AD between symptomatic
side and asymptomatic side was ranged from 0 to −20%,
the predicted result was excellent; when it was ranged from
−20% to −50%, the predicted result was good and when it
was ranged from −50% to −100%, the predicted result was
poor; facial nerve decompression may be considered.
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